Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
Intrinsic Value
Shanghai Pharmaceuticals Holding Co Ltd is a CN-based company operating in Health Care Providers & Services industry. [ Read More ]
The intrinsic value of one Shanghai Pharmaceuticals Holding Co Ltd stock under the Base Case scenario is 42.85 CNY. Compared to the current market price of 17.75 CNY, Shanghai Pharmaceuticals Holding Co Ltd is Undervalued by 59%.
Valuation Backtest
Shanghai Pharmaceuticals Holding Co Ltd
Run backtest to discover the historical profit from buying and selling Shanghai Pharmaceuticals Holding Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
Shanghai Pharmaceuticals Holding Co Ltd
| Current Assets | 162.4B |
| Cash & Short-Term Investments | 38.7B |
| Receivables | 81.9B |
| Other Current Assets | 41.8B |
| Non-Current Assets | 49.5B |
| Long-Term Investments | 10.9B |
| PP&E | 18.3B |
| Intangibles | 17.8B |
| Other Non-Current Assets | 2.6B |
| Current Liabilities | 122.4B |
| Accounts Payable | 47.9B |
| Accrued Liabilities | 10.9B |
| Short-Term Debt | 51.6B |
| Other Current Liabilities | 11.9B |
| Non-Current Liabilities | 21.1B |
| Long-Term Debt | 7.3B |
| Other Non-Current Liabilities | 13.7B |
Earnings Waterfall
Shanghai Pharmaceuticals Holding Co Ltd
|
Revenue
|
260.3B
CNY
|
|
Cost of Revenue
|
-229.3B
CNY
|
|
Gross Profit
|
31B
CNY
|
|
Operating Expenses
|
-22.2B
CNY
|
|
Operating Income
|
8.9B
CNY
|
|
Other Expenses
|
-5.1B
CNY
|
|
Net Income
|
3.8B
CNY
|
Free Cash Flow Analysis
Shanghai Pharmaceuticals Holding Co Ltd
Profitability Score
Profitability Due Diligence
Shanghai Pharmaceuticals Holding Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Shanghai Pharmaceuticals Holding Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Shanghai Pharmaceuticals Holding Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Score
Shanghai Pharmaceuticals Holding Co Ltd's solvency score is 51/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Shanghai Pharmaceuticals Holding Co Ltd
According to Wall Street analysts, the average 1-year price target for Shanghai Pharmaceuticals Holding Co Ltd is 21.79 CNY with a low forecast of 13.13 CNY and a high forecast of 28.14 CNY.
Shareholder Return
Price
Shanghai Pharmaceuticals Holding Co Ltd
| Average Annual Return | 0.44% |
| Standard Deviation of Annual Returns | 8.95% |
| Max Drawdown | -40% |
| Market Capitalization | 50.6B CNY |
| Shares Outstanding | 2 848 046 800 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Shanghai Pharmaceuticals Holding Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 47,056 full-time employees. Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The firm's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The firm's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The firm distributes its products both in the domestic market and to overseas markets.
Contact
IPO
Employees
Officers
The intrinsic value of one Shanghai Pharmaceuticals Holding Co Ltd stock under the Base Case scenario is 42.85 CNY.
Compared to the current market price of 17.75 CNY, Shanghai Pharmaceuticals Holding Co Ltd is Undervalued by 59%.
You don't have any saved screeners yet
